Programme Category
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Identifier Code
Call
Summary
This is a Pathfinder challenge Call and it aims at reinforcing critical components of the European cell and gene therapy community, such as focused research consortia, start-ups and spinoffs, in their ability to compete and sustain in this fiercely competitive field, full of challenges and obstacles all along the way from discovery to the manufacturing step. Proposals submitted to this call should effectively address exactly that, by proposing convincing technological solutions and/or new breakthrough concepts that go far beyond the current state-of-the-art.
Detailed Call Description
Proposers are invited to submit disease-specific or non-disease-specific proposals, focused on emerging technologies or technological solutions aimed to overcome the current cell and gene therapy challenges in one or several the areas listed below, but without being restricted only to these areas:
- Advancing cell therapy manufacturing and products to a clinical stage
- Improving adoptive cell therapies (CAR-T, TCR, TIL)
- Identifying next generation cell therapies for cancer
- Applying cell therapy to treat cancer patients in a personalised manner
- Improving the effectiveness and lowering the risks of gene delivery systems (vectors)
- Improving gene therapy manufacturing processes and production
In order for the proposal to be accepted, it must be focused on emerging technologies or breakthrough new concept-based technological solution that go far beyond the current state-of-the art, aimed to overcome cell and gene therapy challenges and obstacles companies are currently being faced with, at the preclinical or clinical level or bio-manufacturing level.
The gender dimension in research content should be taken into account, where relevant.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
Thematic Categories
- Education and training
- Health
- Research, Technological Development and Innovation
- Small-Medium Enterprises and Competitiveness
Eligibility for Participation
- Educational Institutions
- National Contact Points - NCPs
- Private Bodies
- Researchers/Research Centers/Institutions
- Small and Medium Enterprises (SMEs)
Call Opening Date
Call Closing Date
National Contact Point(s)
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Phone Number: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Persons:
Ms Katerina Karakasidou
Scientific Officer
Contact Phone: +357 22 205 036
Contact Email: kkarakasidou@research.org.cy
Dr Kalypso Sepou
Head of European Programmes Department
Contact Phone: +357 22 205066
Contact Email: kalypso@research.org.cy
EU Contact Point
European Innovation Council: https://eic.ec.europa.eu/contact-form_en